Organogenesis Holdings Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 65.26%69.16%64.43%70.90%74.19%75.57%76.71%75.42%75.99%
EBT Margin -10.60%-7.33%-33.47%-14.77%5.25%13.50%4.50%2.40%-0.58%
EBIT Margin -6.33%-2.77%-26.65%-11.44%7.89%15.45%4.95%2.89%-0.27%
EBITDA Margin -6.33%-2.77%-26.65%-11.44%7.89%15.45%4.95%2.89%-0.27%
Operating Margin -6.33%-2.77%-26.65%-11.44%7.89%15.45%4.95%2.89%-0.27%
Net Margin -10.64%-4.44%-33.51%-15.05%5.09%20.31%3.44%1.14%-0.19%
FCF Margin -4.49%-2.98%-32.30%-15.14%-3.61%6.58%-2.00%1.51%0.87%
Efficiency
Inventory Average 13.80M15.65M18.34M19.45M21.55M25.36M26.41M24.90M26.52M27.24M
Assets Average 230.08M156.20M170.07M172.26M171.36M197.66M255.45M366.74M446.31M454.69M478.96M
Equity Average -5.16M15.86M39.80M27.88M18.00M34.20M98.70M191.57M253.50M272.17M270.78M
Invested Capital 5.00M36.83M49.39M72.56M63.20M62.81M105.58M211.81M315.40M270.21M284.15M262.90M
Asset Utilization Ratio 0.861.241.181.241.291.321.321.271.010.951.01
Leverage & Solvency
Interest Coverage Ratio -1.56-0.69-4.78-3.322.379.9811.105.72-0.83
Debt to Equity -3.730.671.371.934.260.980.540.300.270.24
Debt Ratio 0.380.190.250.270.310.250.260.170.160.14
Equity Ratio 0.02-0.100.290.180.140.070.250.490.540.590.610.53
Times Interest Earned -1.56-0.69-4.78-3.322.379.9811.105.72-0.83
Dividends & Payouts
FCF Payout Ratio -0.83
Valuation
Enterprise Value -1.04M71.85M350.06M689.97M693.88M599.94M455.52M2,098.62M1,074.12M195.79M435.71M288.09M
Market Capitalization 384.40M350.18M690.07M694.00M600.13M455.72M2,183.43M1,188.65M299.08M540.05M424.24M
Return Ratios
Return on Sales -0.11%-0.04%-0.34%-0.15%0.05%0.20%0.03%0.01%-0.02%
Return on Capital Employed -0.03%-0.52%-0.22%0.14%0.25%0.06%0.03%0.00%
Return on Invested Capital -0.14%0.16%0.06%0.02%
Return on Assets -0.03%-0.42%-0.20%0.07%0.26%0.03%0.01%-0.02%
Return on Equity 1.46%-4.09%-1.13%0.17%0.49%0.06%0.02%-0.04%